Concepedia

Author

Sarah Lindner

Goethe University FrankfurtORCID

Also Known As

Lindner, Sarah, S. Lindner, Sarah Kayser, Sarah Lindner

33

Publications

359

Citations

8

H-Index

43

Concepts

All Affiliations

Goethe University FrankfurtMemorial Sloan Kettering Cancer CenterCornell UniversityUniversity Hospital FrankfurtKettering University
SL

About

Sarah Lindner is an author at Goethe University Frankfurt specializing in medicine, immunology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

191

2

Immunology

3

3

87

3

Health Sciences

2

2

95

4

Blood Transplantation

1

1

23

5

Cell Biology

1

1

18

Sarah Lindner

×

8

Publications

341

Citations

8

H-Index

YearCitations

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

Niloufer Khan, Sarah Lindner, Antonio L. C. Gomes,

Blood

2020

78

CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping

Jasmin D. Haslbauer, Sarah Lindner, Silvia Valbuena-López,

International Journal of Cardiology

2018

72

Clinical impact of colonization with multidrug‐resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia

Sebastian Scheich, Sarah Lindner, Rosalie Koenig,

Cancer

2017

48

Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease

Sarah Lindner, Oriana Miltiadous, Rúben J. Ramos,

Nature Microbiology

2024

46

Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation

Erik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist,

Nature Cancer

2024

32

Impact on soil physical properties of using large-grain legumes for catch crop cultivation under different tillage conditions

Jan Rücknagel, Philipp Götze, Barbara Koblenz,

European Journal of Agronomy

2016

24

Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival

Sebastian Scheich, Rosalie Koenig, Anne C. Wilke,

PLoS ONE

2018

23

Abstract 3022: BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML)

Arne Scholz, Thomas Oellerich, Akhtar Hussain,

Cancer Research

2016

18

Page 1